Vimentin Antikörper (VIM)

Details for Product anti-VIM Antibody No. ABIN6269441
Target
Reaktivität
Human, Maus, Ratte
451
207
204
103
92
65
58
49
45
35
33
32
17
13
11
10
8
5
4
2
2
2
2
1
1
1
1
1
1
1
Wirt
Kaninchen
223
209
13
10
7
6
6
2
Klonalität
Polyklonal
Konjugat
Dieser Vimentin Antikörper ist unkonjugiert
30
18
18
10
8
8
8
8
8
8
7
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
1
1
Applikation
ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blotting (WB)
337
166
139
136
119
104
60
48
41
39
34
15
13
11
7
6
3
2
2
2
1
1
1
1
1
1
1
Optionen
Immunogen A synthesized peptide derived from human Vimentin
Isotyp IgG
Spezifität Vimentin Antibody detects endogenous levels of total Vimentin
Kreuzreaktivität Human, Maus, Ratte (Rattus)
Reinigung The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
Target
Andere Bezeichnung Vimentin (VIM Antibody Abstract)
Hintergrund

Description: Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally.

Gene: VIM

Molekulargewicht 53kDa
Gen-ID 7431
UniProt P08670
Pathways Caspase Kaskade in der Apoptose
Applikations-hinweise WB 1:500-1:2000 IHC 1:50-1:200 IF 1:200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 mg/mL
Buffer Rabbit IgG in phosphate buffered saline ,  pH 7.4, 150  mM NaCl, 0.02 % sodium azide
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Bilder
Image no. 1 for anti-Vimentin (VIM) antibody (ABIN6269441) ABIN6269442 at 1/200 staining human lymphoma tissue sections by IHC-P. The tissue was...
Image no. 2 for anti-Vimentin (VIM) antibody (ABIN6269441) ABIN6269442 staining A549 cells by ICC/IF. Cells were fixed with PFA and permeabilize...
Image no. 3 for anti-Vimentin (VIM) antibody (ABIN6269441) ABIN6269442 at 1/200 staining human lymphoma tissue sections by IHC-P. The tissue was...
Image no. 4 for anti-Vimentin (VIM) antibody (ABIN6269441) Western blot analysis of extracts of various sample,using Vimentin antibody.
Image no. 5 for anti-Vimentin (VIM) antibody (ABIN6269441) Vimentin Antibody for IHC in human liver tissue
Image no. 6 for anti-Vimentin (VIM) antibody (ABIN6269441) Western blot analysis of extracts of mouse brain,using Vimentin antibody.
Image no. 7 for anti-Vimentin (VIM) antibody (ABIN6269441) Western blot analysis of Vimentin expression in HepG2 whole cell lysates,The lane on ...
Produkt verwendet in: Yang, Zhou, Zhu, Fan, Liu, Duan, Tang, Shou, Zuo: "miR-200b-containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial-mesenchymal transition." in: Journal of gastroenterology and hepatology, Vol. 32, Issue 12, pp. 1966-1974, 2018 (PubMed).

Xu, Sun, Fang, Song, Yan, Chen, Jiang, Fei, Zhao, Leboeuf, Li, Wang, Janin, Wang, Zhao: "JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide." in: Scientific reports, Vol. 7, Issue 1, pp. 7433, 2018 (PubMed).

Zhou, Qin, Li, Li, Wang, Zhang, Chen, Li: "Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis." in: Journal of experimental & clinical cancer research : CR, Vol. 36, Issue 1, pp. 115, 2018 (PubMed).

Ai, Zhang, Gao, Qin, Zhong, Gu, Li, Qiao, Tian, Cui, Yang, Bi, Xiao, Chen, Liu, Zhou, Sun, Yang: "Sesquiterpene binding Gly-Leu-Ser/Lys-"co-adaptation pocket" to inhibit lung cancer cell epithelial-mesenchymal transition." in: Oncotarget, Vol. 8, Issue 41, pp. 70192-70203, 2018 (PubMed).

Duan, Jia, Zhang, Long, Tang: "Endothelin-1-induced expression of α-smooth muscle actin in human myometrial fibroblasts." in: The journal of obstetrics and gynaecology research, Vol. 44, Issue 3, pp. 540-546, 2018 (PubMed).

Shao, Zhang, Ma, Lu, Meng, Li, Wang, Chen, Zhang, Han, Liu, Ma: "MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition." in: Gene, Vol. 652, pp. 48-58, 2018 (PubMed).

Meng, Chen, Han, Qian, Wang, Zhong, Qin, Zhang, Gao, Lei, Yang, Yang, Zhang, Liu, Liu, Zhou, Sun, Yang: "Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma." in: Cancer research, Vol. 78, Issue 15, pp. 4150-4162, 2018 (PubMed).

Liu, Du, Zhang, Lv, Xiong, Zhang, Li, He, Li, Liu: "Autophagy contributes to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis." in: Biology of reproduction, 2018 (PubMed).

Li, Xiao, Yang, Qin, Gao, Liu, Zhou: "Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway." in: Respiratory research, Vol. 19, Issue 1, pp. 111, 2018 (PubMed).

Wang, Bao, Liu, Wang, Hao: "Effects of endometrial stem cell transplantation combined with estrogen in the repair of endometrial injury." in: Oncology letters, Vol. 16, Issue 1, pp. 1115-1122, 2018 (PubMed).

Meng, Chen, Lei, Han, Zhong, Wang, Liu, Gao, Zhang, Tan, Liu, Zhou, Sun, Yang: "Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma." in: Oncogene, 2018 (PubMed).

Park, Jin, Park, Yeon, Xu, Han, Rha, Kim: "IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis." in: PLoS ONE, Vol. 12, Issue 8, pp. e0181806, 2017 (PubMed).

Li, Zhang, Sun, Sun, Shi, Liu, Liu: "MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells." in: International journal of oncology, Vol. 47, Issue 4, pp. 1379-92, 2016 (PubMed).

Hou, Li, Shi, Li, Liu, Zong, Ren, Chai, Xu: "Yi Ai Fang, a traditional Chinese herbal formula, impacts the vasculogenic mimicry formation of human colorectal cancer through HIF-1α and epithelial mesenchymal transition." in: BMC complementary and alternative medicine, Vol. 16, Issue 1, pp. 428, 2016 (PubMed).